U.S. flag

An official website of the United States government

NM_003054.6(SLC18A2):c.946C>G (p.Pro316Ala) AND Brain dopamine-serotonin vesicular transport disease

Germline classification:
Pathogenic (1 submission)
Last evaluated:
Dec 11, 2023
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV004576976.1

Allele description [Variation Report for NM_003054.6(SLC18A2):c.946C>G (p.Pro316Ala)]

NM_003054.6(SLC18A2):c.946C>G (p.Pro316Ala)

Gene:
SLC18A2:solute carrier family 18 member A2 [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
10q25.3
Genomic location:
Preferred name:
NM_003054.6(SLC18A2):c.946C>G (p.Pro316Ala)
HGVS:
  • NC_000010.11:g.117257847C>G
  • NM_003054.6:c.946C>GMANE SELECT
  • NP_003045.2:p.Pro316Ala
  • NC_000010.10:g.119017358C>G
  • NM_003054.4:c.946C>G
Protein change:
P316A; PRO316ALA
Links:
OMIM: 193001.0003; dbSNP: rs1589981178
NCBI 1000 Genomes Browser:
rs1589981178
Molecular consequence:
  • NM_003054.6:c.946C>G - missense variant - [Sequence Ontology: SO:0001583]

Condition(s)

Name:
Brain dopamine-serotonin vesicular transport disease (PKDYS2)
Synonyms:
Parkinsonism-dystonia, infantile, 2; PARKINSONISM-DYSTONIA 2, INFANTILE-ONSET; BRAIN MONOAMINE VESICULAR TRANSPORT DISEASE
Identifiers:
MONDO: MONDO:0018130; MedGen: C4303546; OMIM: 618049

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV004175904OMIM
no assertion criteria provided
Pathogenic
(Dec 11, 2023)
germlineliterature only

Padmakumar, M., Jaeken, J., Ramaekers, V., Lagae, L., Greene, D., Thys, C., Van Geet, C., BioResource, N., Stirrups, K., Downes, K., Turro, E., Freson, K. A novel missense variant in SLC18A2 causes recessive brain monoamine vesicular transport disease and absent serotonin in platelets. JIMD Rep. 47: 9-16, 2019.

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlinenot providednot providednot providednot providednot providednot providedliterature only

Details of each submission

From OMIM, SCV004175904.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedliterature onlynot provided

Description

In a 5-year-old boy, born to consanguineous parents, with infantile parkinsonism-dystonia-2 (PKDYS2; 618049), Padmakumar et al. (2019) identified homozygosity for a c.946C-G transversion in the SLC18A2 gene, resulting in a pro316-to-ala (P316A) substitution at a highly conserved residue. The mutation, which was identified by whole-genome sequencing and confirmed by Sanger sequencing, was present in heterozygous state in the parents. The mutation was not present in the gnomAD database.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlinenot providednot providednot providednot providednot providednot providednot providednot provided

Last Updated: Nov 24, 2024